Theranostics with simultaneous diagnosis and therapy functions are potential to greatly
improve the therapeutic efficacy and reduce side effects. Fluorescence imaging has …

Over the past decade, more interests have been aroused in engineering protein-based
nanoformulations for cancer treatment. This excitement originates from the success of FDA …

While the miniaturization and motility of artificial nanomotors made them popular tools for
exploring novel and innovative biomedical cancer treatment strategies, the integration of …

Objective To assess the impact of a novel molecular imaging technique, 68Ga‐(HBED‐CC)‐
prostate‐specific membrane antigen (PSMA) positron emission tomography/computed …

Our aim is to help put nuclear medicine at the forefront of quantitation on the path to the
realization of personalized medicine. We propose and evaluate (Part I) advanced image …

Theranostics or theragnostics are new terms which start to appear occasionally in
publications from 2001 onwards, with a marked increase in references from 2011. In the last …

Purpose The aim of this communication was to assess the efficacy of directed
oligometastatic radiotherapy (RT) based on 68 Ga-PSMA PET/CT in patients with prostate …

Bladder cancer, the most common tumour of the urinary tract, ranks fifth among all tumour
entities. While local treatment or intravesical instillation of bacillus Calmette–Guerin (BCG) …

Unmet needs in urothelial cancer management represent an important challenge in our
effort to improve long-term overall and disease-free survival rates with no significant …

A better understanding of key regulatory pathways involved in cancers has led to the
development of molecularly targeted therapies. Molecular profiling based on genomics …